|
About:
|
Exova Diagnostics validated multiple LDT qualitative multi-target COVID-19 molecular diagnostics tests that are used to screen and detect the presence of the virus that causes COVID-19 (SARS-CoV-2) in upper and lower respiratory specimens (such as nasopharyngeal or oropharyngeal swabs, sputum, tracheal aspirates, bronchoalveolar lavage, and saliva).
|